Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma

• Auteurs principaux: Yanxin Sun (Auteur), Wei Jiang (Auteur), Ruiheng Duan (Auteur), Lianyue Guan (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary malignancy of the liver, following hepatocellular carcinoma (HCC). Surgical resection remains the only potentially curative treatment for ICC. However, due to its high malignancy and propensity for postoperative recurrence, the...